MIs in ATOMIC-AHF Trial Pose No Problems

HFSA 2013 — ORLANDO — Five myocardial infarctions in the Phase II ATOMIC-AHF study of the novel inotropic agent omecamtiv mecarbil might not be related to the drug, researchers suggested.


< Back to Listings